CLINICAL OUTCOMES AND HEALTH CARE RESOURCE UTILIZATION IN A 1-YEAR OBSERVATIONAL STUDY OF PATIENTS WITH NON-FOCAL DISABLING SPASTICITY WHO ARE RESISTANT OR INTOLERANT TO ORAL THERAPY TREATED WITH INTRATHECAL BACLOFEN THERAPY AT THE INSTITUT ...
Author(s)
Slof J1, Serrano D2, Álvarez López-Dóriga M3, Álvarez M3, Marqués T4, Benito J4, Vidal J4
1Universitat Autònoma de Barcelona, Bellaterra, Spain, 2Autonomous Consultant, Barbera del Valles, Spain, 3Medtronic Ibérica, S.A., Madrid, Spain, 4Institut Guttmann, Barcelona, Spain
OBJECTIVES To assess clinical outcomes, healthcare resource utilization and associated costs of intrathecal baclofen therapy (ITB) for the treatment of non-focal disabling spasticity (N-FDS) in patients who are resistant or intolerant to oral therapy. METHODS Observational, non-interventional, prospective, single-center study of 1 year follow-up from ITB implant onward. RESULTS
Conference/Value in Health Info
2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands
Value in Health, Vol. 17, No. 7 (November 2014)
Code
PND34
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Neurological Disorders